Larimar Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Larimar Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Larimar Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Larimar Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Larimar Therapeutics Inc (Larimar Therapeutics) is a clinical-stage biotechnology company that focuses on developing treatments for complex rare diseases The company's lead product is nomlabofusp, recombinant fusion protein designed to the treatment of Friedreich’s ataxia-a rare genetic disorder characterized by the deficiency of frataxin (FXN), an essential protein for mitochondrial function. Larimar Therapeutics leverages its proprietary protein replacement therapy platform to design fusion proteins targeting rare diseases associated with intracellular bioactive compound deficiencies. The company operates in Australia and the US. Larimar Therapeutics is headquartered in Bala Cynwyd, Pennsylvania, the US.
Headquarters
United States of America
Address
Three Bala Plaza East. Suite 506, Bala Cynwyd, Pennsylvania, 19004
Website
www.larimartx.com/
Telephone
1 844 5119056
No of Employees
71
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
LRMR (NASD)
EPS
XYZ
Net Income (2024)
XYZ
-105.5%
(2024 vs 2023)
Market Cap*
$333.5M
* As of and is in US$
Larimar Therapeutics Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline Product: | Larimar |
| Nomlabofusp: Friedreich’s Ataxia |
Competitor Comparison
| Key Parameters | Larimar Therapeutics Inc | Neurocrine Biosciences Inc | PTC Therapeutics Inc | Voyager Therapeutics Inc | Reata Pharmaceuticals Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Bala Cynwyd | San Diego | Warren | Lexington | Cambridge |
| State/Province | Pennsylvania | California | New Jersey | Massachusetts | Massachusetts |
| No. of Employees | 71 | 2,000 | 991 | 141 | 321 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Joseph Truitt | Chairman | Executive Board | 2020 | 61 |
| Carole S. Ben-Maimon, M.D. | President; Chief Executive Officer; Director | Executive Board | 2020 | 67 |
| Michael Celano | Secretary; Chief Financial Officer | Senior Management | 2021 | 67 |
| Russell G. Clayton | Chief Medical Officer | Senior Management | 2023 | 65 |
| Keith E. Lynch | Vice President - CMC Technical Operations | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer